Feb 09, 2026 XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
Dec 30, 2025 XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab
Mar 18, 2026 • 6:00 AM EDT XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements
Mar 12, 2026 • 6:30 AM EDT XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
